Cardiogenic Shock in the Patient with Peripartum Cardiomyopathy

Author(s): Stoddard Amy M

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.25

Expires Dec 31, 2026

Topics: MultiSystem, Pharmacology

Population: Adult

Role: APRN, Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

An increasing incidence of paripartum cardiomyopathy (PPCM) in the U.S. disproportionally affects African American women due to genetics. This session covers the pathophysiology, diagnostics and treatment of cardiogenic shock specific to the PPCM patient. Case studies provide participants with advanced knowledge regarding the diagnosis and treatment of cardiogenic shock to achieve optimal outcomes for mother and fetus in the PPCM population.

Objectives

  • Describe the pathophysiology of PPCM and how cardiogenic shock can develop.
  • Discuss the tests used in diagnosing and treating cardiogenic shock in the PPCM patient.
  • Analyze the management and pharmacologic options in the treatment of cardiogenic shock in the PPCM patient.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.